Rodzajewska, A. et al. 2023. Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation. Journal of Education, Health and Sport. 31, 1 (Aug. 2023), 138–147. DOI:https://doi.org/10.12775/JEHS.2023.31.01.012.